Literature DB >> 8210833

Etiology of bladder cancer.

T Shirai1.   

Abstract

That the etiology of bladder cancer involves environmental factors is well documented. Most chemical carcinogens probably affect the urothelial cells via their presence in the urine. As an important cofactor, cell-proliferative activity may be increased by urinary bladder infection, irritation by bladder stones or through the action of a variety of direct acting chemicals or agents. Among the known causative factors, avoidable major ones are occupational exposure to certain chemicals such as benzidine and 4-aminobiphenyl, cigarette smoking, and bilharzial infection, which could be eradicated by a combination of praziquantel, antihelminth therapy, education, and improvements in social welfare. An anticarcinogenic drug, cyclophosphamide, used as an immunosuppressive agent also seems to be associated with a high risk of idiopathic induction of bladder cancer and physicians should therefore pay particular attention to its diverse effects when considering its prescription. In contrast to the above, the consumption of coffee and tea containing artificial sweeteners is now thought unlikely to be a major risk. So far there is no good biochemical tool to predict individual exposure to bladder carcinogens/or relative risk of bladder-cancer development. However, acetylation capacity can be applied to assess susceptibility to carcinogenic amines in people exposed in their working environment. Progress in molecular-biological analysis will hopefully bring to light etiology-specific DNA damage in bladder tumors, and it may prove useful for prediction of tumor behavior in the near future.

Entities:  

Mesh:

Year:  1993        PMID: 8210833

Source DB:  PubMed          Journal:  Semin Urol        ISSN: 0730-9147


  12 in total

Review 1.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

2.  Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.

Authors:  Wei Tang; Yi-Ping Fu; Jonine D Figueroa; Núria Malats; Montserrat Garcia-Closas; Nilanjan Chatterjee; Manolis Kogevinas; Dalsu Baris; Michael Thun; Jennifer L Hall; Immaculata De Vivo; Demetrius Albanes; Patricia Porter-Gill; Mark P Purdue; Laurie Burdett; Luyang Liu; Amy Hutchinson; Timothy Myers; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina Garcia-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Amanda Black; Eric J Jacobs; W Ryan Diver; Susan M Gapstur; Jarmo Virtamo; David J Hunter; Joseph F Fraumeni; Stephen J Chanock; Debra T Silverman; Nathaniel Rothman; Ludmila Prokunina-Olsson
Journal:  Hum Mol Genet       Date:  2012-01-06       Impact factor: 6.150

3.  Durability of and role of AKT in FGF7p urothelial protection against cyclophosphamide.

Authors:  Sridhar Tatarao Narla; Lori Rice; David Ostrov; Daniel Scott Bushnell; Joanne Lindsey Duara; Carlton Matthew Bates
Journal:  Physiol Rep       Date:  2022-06

4.  Role of ERK signaling in bladder urothelium in response to cyclophosphamide injury.

Authors:  Sridhar Tatarao Narla; Joanne Lindsey Duara; Daniel Scott Bushnell; Mehdi Nouraie; Jacqueline Holden; Katherine Pfister; Peter C Lucas; Sunder Sims-Lucas; Carlton Matthew Bates
Journal:  Physiol Rep       Date:  2022-07

5.  Human epididymis protein 4 is a biomarker for transitional cell carcinoma in the urinary system.

Authors:  Zhu Xi; Ma LinLin; Tian Ye
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

6.  Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients.

Authors:  Nadia S Metwally; Sanaa A Ali; Azza M Mohamed; Hussein M Khaled; Samia A Ahmed
Journal:  Cancer Cell Int       Date:  2011-04-07       Impact factor: 5.722

7.  Position- and base pair-specific comparison of p53 mutation spectra in human tumors: elucidation of relationships between organs for cancer etiology.

Authors:  W K Lutz; T Fekete; S Vamvakas
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

8.  AKT Signaling Downstream of KGF Is Necessary and Sufficient for Blocking Cyclophosphamide Bladder Injury.

Authors:  Sridhar T Narla; Daniel S Bushnell; Joanne L Duara; Carlton M Bates
Journal:  Am J Pathol       Date:  2022-01-19       Impact factor: 5.770

9.  Loss of Fibroblast Growth Factor Receptor 2 (FGFR2) Leads to Defective Bladder Urothelial Regeneration after Cyclophosphamide Injury.

Authors:  Sridhar T Narla; Daniel S Bushnell; Caitlin M Schaefer; Mehdi Nouraie; Justin T Tometich; Timothy W Hand; Carlton M Bates
Journal:  Am J Pathol       Date:  2020-12-30       Impact factor: 5.770

10.  Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.

Authors:  Ahmed S Abdulamir; Rand R Hafidh; Haider S Kadhim; Fatimah Abubakar
Journal:  J Exp Clin Cancer Res       Date:  2009-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.